A trailblazing study, employing actual cannabis donations, blasts this assumption to smithereens, establishing once and for all, a lack of correlation between high THC cannabis usage and increased anxiety, depression, or psychosis-like symptoms.
- An innovative study successfully clarifies a crucial question by using donated cannabis to establish that high-potency cannabis does not facilitate an upswing in anxiety, depression, or psychosis-like symptoms.
- Previous analyses relied heavily on self-reported cannabis strength, leading to the possibility of inherent bias.
- A more accurate approach involves measuring the actual THC concentration of the cannabis used by participants.
- The study involved a vast swath of 410 participants, ranging in age from 16 to 24 years old, all regularly using cannabis.
- The findings debunk the popular notion contending that high-potency cannabis leads to increased cannabis dependence and mental health issues.
Researchers at the vanguard of cannabis study at the University of Bath have dramatically shifted the perspective on cannabis use and mental health. Unlike their predecessors, whose studies were diminished by the subjective reporting of cannabis potency, this cutting-edge study offers a decisive scientific edge by analysing physically-donated cannabis, thereby bypassing the likelihood of bias perception and self-reporting errors.
The study embraced an inclusive approach, welcoming a diverse participant base of 410 individuals aged 16 to 24, with the one common denominator being their regular monthly use of cannabis. Vital to the study was ensuring participants had no prior psychosis diagnosis or learning impairments.
The surprising results showed a preference among 39% of participants toward high-strength cannabis over lower-strength variants. However, the average THC level reported by high-strength cannabis aficionados was 8.95%, marginally higher than the 7.90% reported by those favouring a lower-strength hit.
Most notably, when the data was heavily scrutinised for correlations between high-potency cannabis use and mental health issues, the findings pointed toward a slight increase in cannabis dependence among high-potency users. But this risk remained unchanged even after controlling for variables like age, sex, alcohol, tobacco use and consumption of other illicit substances.
When researchers adjusted for cannabis usage frequency, they unveiled only weak evidence for a very small effect of cannabis potency preference on cannabis dependence. Essentially, it’s frequency of use, rather than the potency that could contribute to cannabis dependence.
In summing up their breakthrough study, the researchers highlighted the importance of refining research methodology to achieve reliable outcomes on cannabis use. In understanding cannabis’ complexity, it may defy our past apprehensions, and continue to surprise us in the most reassuring ways.
What BRITISH CANNABIS has to say:
This groundbreaking study lays an essential foundation for an objective discussion on cannabis use. Its contribution to rebuffing overstated fears around high-potency cannabis use and mental health issues is a stride forward towards dispelling enduring misguided beliefs about cannabis. With perpetually accurate and refined studies, we can project a new understanding of cannabis and its rightful place in our society.